HDAC9 and breast carcinoma: Moreover, the effects of this combination were very similar to the epigenetic effects exhibited by demethylation agent 5-azacytidine (5-aza) and HDAC inhibitor Trichostatin A (TSA) in combination, indicating that these polyphenols can be used as a chemotherapeutic strategy for breast cancer [119].